NovaBay Pharmaceuticals, Inc.
NBY
$0.6101
-$0.0081-1.31%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 364.45% | -85.29% | -77.65% | -82.99% | -51.33% |
| Total Receivables | -57.49% | -42.79% | -23.14% | -79.15% | -60.00% |
| Inventory | -- | 52.69% | -86.11% | -81.42% | -82.98% |
| Prepaid Expenses | -57.56% | -24.61% | 12.80% | -24.77% | 5.04% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 50.00% | -94.34% | 52.63% | -52.53% | -29.41% |
| Total Current Assets | 151.68% | -72.95% | -72.25% | -79.91% | -63.71% |
|
|
|||||
| Total Current Assets | 151.68% | -72.95% | -72.25% | -79.91% | -63.71% |
| Net Property, Plant & Equipment | -72.46% | -27.11% | -32.04% | -31.42% | -30.81% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.42% | -3.42% | -1.20% | -4.03% | -0.21% |
| Total Assets | 84.28% | -62.11% | -69.83% | -75.48% | -63.87% |
|
|
|||||
| Total Accounts Payable | -28.38% | -31.24% | -58.18% | -16.61% | -2.70% |
| Total Accrued Expenses | 25.14% | -34.22% | -52.12% | -44.14% | -44.87% |
| Short-term Debt | -91.66% | -50.31% | -95.98% | -41.27% | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.47% | 8.15% | -19.59% | -19.75% | -19.53% |
| Total Finance Division Other Current Liabilities | 24.78% | -30.09% | -27.93% | -61.08% | -51.50% |
| Total Other Current Liabilities | 24.78% | -30.09% | -27.93% | -61.08% | -51.50% |
| Total Current Liabilities | -21.84% | -33.54% | -56.60% | -40.49% | -11.28% |
|
|
|||||
| Total Current Liabilities | -21.84% | -33.54% | -56.60% | -40.49% | -11.28% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -91.66% | -50.31% | -95.98% | -41.27% | -- |
| Capital Leases | -38.71% | -36.01% | -34.00% | -32.41% | -31.15% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -28.71% | -37.90% | -51.76% | -38.99% | -12.43% |
|
|
|||||
| Common Stock & APIC | 2.73% | 4.03% | 7.36% | 5.31% | 6.82% |
| Retained Earnings | 1.49% | -4.92% | -10.00% | -9.82% | -11.60% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 564.98% | -109.90% | -78.93% | -109.68% | -122.39% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -99.60% | -99.69% | -99.70% | -99.72% | -50.05% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -99.60% | -99.69% | -99.70% | -99.72% | -50.05% |
|
|
|||||
| Total Common Equity | 564.98% | -109.90% | -78.93% | -109.68% | -122.39% |
| Total Preferred Equity | -99.60% | -99.69% | -99.70% | -99.72% | -50.05% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3,754.38% | -103.89% | -84.77% | -107.21% | -98.20% |
|
|
|||||